earthnewsreport.com
FDA advisors recommend first-ever RSV vaccine from Pfizer, despite possible Guillain-Barre risks - Earth News Report
Blood sample for respiratory syncytial virus (RSV) testJarun011 | Istock | Getty Images The Food and Drug Administration's independent advisors on Tuesday recommended what would be the world's first RSV vaccine, a shot from Pfizer for adults ages 60 and older, despite safety concerns after two trial participants developed a rare neurological disorder. A majority